Released Oct 15, 2020, after the close
10-Q filed Oct 19, 2020, 19 days after period end · 0001035267-20-000166
Q3 2020 · 10-Q
Revenue$1.08B$1.08B −4.5% vs Q3 2019+26.5% vs Q2 2020
Net Income$313.90M$313.90M −20.9% vs Q3 2019+361.6% vs Q2 2020
EPS Diluted$2.60$2.60 −21.9% vs Q3 2019+356.1% vs Q2 2020
Gross Profit$724,300,000−7.8%
Operating Income$270,400,000−26.1%
Operating Cash Flowderived$274,600,000−30.7%
Free Cash Flowderived$210,200,000−32.1%
Margins · derived
Gross margin67.2%−2.4 pt vs Q3 2019
Operating margin25.1%−7.3 pt vs Q3 2019
Net margin29.1%−6.0 pt vs Q3 2019
What the release said
The release
Same quarter
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $1.08B | $1.13B | $920.90M | $807.80M |
| Net Income | $313.90M | $396.80M | $292.50M | $298.60M |
| EPS Diluted | $2.60 | $3.33 | $2.45 | $2.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR